Literature DB >> 27362915

Sex-differential heterologous (non-specific) effects of vaccines: an emerging public health issue that needs to be understood and exploited.

Katie L Flanagan1, Magdalena Plebanski1,2.   

Abstract

INTRODUCTION: Vaccines have heterologous effects on the immune system, leading to altered susceptibility to a range of pathogens, and possibly allergy and autoimmunity. Effects are often sex-differential. This review discusses the evidence, mechanisms and public health implications of the non-specific effects of vaccines (NSEs). Areas covered: This article firstly discusses the World Health Organization systematic review of the evidence for sex-differential heterologous effects of vaccines, and further PubMed indexed studies on NSEs on susceptibility to infectious diseases, allergy, autoimmunity and malignancy in animals and humans. Potential immunological mechanisms are evaluated, including sex-differential effects. Finally it describes how advances in systems biology might be applied to study such effects. Expert commentary: This section points out the need to understand immune mechanisms in order to exploit beneficial vaccine effects, and diminish deleterious ones. It suggests analysis of vaccine effects by sex is important, and discusses the future for personalised vaccines that take these effects into account.

Entities:  

Keywords:  Sex; adaptive immunity; allergy; autoimmunity; expanded program on immunisation; innate immunity; non-targeted effects; personalised vaccines; systems vaccinology

Mesh:

Year:  2016        PMID: 27362915     DOI: 10.1080/14760584.2016.1203260

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  9 in total

1.  Penta is associated with an increased female-male mortality ratio: cohort study from Bangladesh.

Authors:  Syed Manzoor Ahmed Hanifi; Sofie Biering-Sørensen; Aksel Karl Georg Jensen; Peter Aaby; Abbas Bhuiya
Journal:  Hum Vaccin Immunother       Date:  2020-06-23       Impact factor: 3.452

2.  Synthetic Nanoparticles That Promote Tumor Necrosis Factor Receptor 2 Expressing Regulatory T Cells in the Lung and Resistance to Allergic Airways Inflammation.

Authors:  Rohimah Mohamud; Jeanne S LeMasurier; Jennifer C Boer; Je Lin Sieow; Jennifer M Rolland; Robyn E O'Hehir; Charles L Hardy; Magdalena Plebanski
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

3.  Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette-Guérin Russia Vaccination.

Authors:  Fatoumatta Darboe; Jane U Adetifa; John Reynolds; Safayet Hossin; Magdalena Plebanski; Mihai G Netea; Sarah L Rowland-Jones; Jayne S Sutherland; Katie L Flanagan
Journal:  Front Immunol       Date:  2017-09-08       Impact factor: 7.561

Review 4.  Advances in Oral Subunit Vaccine Design.

Authors:  Hans Van der Weken; Eric Cox; Bert Devriendt
Journal:  Vaccines (Basel)       Date:  2020-12-22

5.  Risk factors for community-acquired pneumonia among adults in Kenya: a case-control study.

Authors:  Esther Muthumbi; Brett S Lowe; Cyprian Muyodi; Esther Getambu; Fergus Gleeson; J Anthony G Scott
Journal:  Pneumonia (Nathan)       Date:  2017-11-25

6.  Negative Correlation between Circulating CD4+FOXP3+CD127- Regulatory T Cells and Subsequent Antibody Responses to Infant Measles Vaccine but Not Diphtheria-Tetanus-Pertussis Vaccine Implies a Regulatory Role.

Authors:  Jorjoh Ndure; Fatou Noho-Konteh; Jane U Adetifa; Momodou Cox; Francis Barker; My Thanh Le; Lady C Sanyang; Adboulie Drammeh; Hilton C Whittle; Ed Clarke; Magdalena Plebanski; Sarah L Rowland-Jones; Katie L Flanagan
Journal:  Front Immunol       Date:  2017-08-14       Impact factor: 7.561

7.  Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines.

Authors:  Mariusz Skwarczynski; Guangzu Zhao; Jennifer C Boer; Victoria Ozberk; Armira Azuar; Jazmina Gonzalez Cruz; Ashwini Kumar Giddam; Zeinab G Khalil; Manisha Pandey; Mohini A Shibu; Waleed M Hussein; Reshma J Nevagi; Michael R Batzloff; James W Wells; Robert J Capon; Magdalena Plebanski; Michael F Good; Istvan Toth
Journal:  Sci Adv       Date:  2020-01-29       Impact factor: 14.136

Review 8.  Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.

Authors:  Katie L Flanagan; Emma Best; Nigel W Crawford; Michelle Giles; Archana Koirala; Kristine Macartney; Fiona Russell; Benjamin W Teh; Sophie Ch Wen
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

9.  Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects.

Authors:  Maria Giulia Mosconi; Francesco Caso; Giorgio Maraziti; Christine Kremer; Luisa Costa; Raffaele Scarpa; Roberto Giacomelli; Valeria Caso
Journal:  Neurol Sci       Date:  2021-12       Impact factor: 3.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.